AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80%Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
| ABX | ||
| 2,622.935 | ||
| 44.7020 | 0.0173% | |
| BISNIS-27 | ||
| 379.830 | ||
| 6.6040 | 0.0177% | |
| DBX | ||
| 2,453.711 | ||
| 1.0220 | 0.0004% | |
| ECONOMIC30 | ||
| 74.854 | ||
| 1.1900 | 0.0162% | |
| ESGQKEHATI | ||
| 94.801 | ||
| 1.3670 | 0.0146% | |
| ESGSKEHATI | ||
| 95.050 | ||
| 1.4660 | 0.0157% | |
| I-GRADE | ||
| 133.898 | ||
| 2.4620 | 0.0187% | |
| AUDRP | ||
| 12,654.530 | ||
| -16.5600 | -0.1307% | |
| EURRP | ||
| 20,225.030 | ||
| -24.2700 | -0.1199% | |
| JPYRP | ||
| 115.027 | ||
| 0.9943 | 0.8719% | |
| SINRP | ||
| 14,134.260 | ||
| 31.3300 | 0.2222% | |
| USDRP | ||
| 18,065.000 | ||
| 33.0000 | 0.1830% | |
